Healix Infusion Therapy Inc is categorized under Specialty Outpatient Clinics, Nec in Sugar Land, TX and active since 2000.
Healix Infusion Therapy Inc was established in 2000, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number by the NAICS.
If you are seeking more information, feel free to contact mangesh nigade at the company’s single location by writing to 14140 Southwest Freeway # 400, Sugar Land, Texas TX 77478 or by phoning (281) 295-4000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Healix Infusion Therapy Inc |
| Contact Person: | mangesh nigade |
| Address: | 14140 Southwest Freeway # 400, Sugar Land, Texas 77478 |
| Phone Number: | (281) 295-4000 |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Specialty Outpatient Clinics, Nec |
| Share This Business: |
Healix Infusion Therapy Inc was started in 2000 to provide professional Specialty Outpatient Clinics, Nec under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact mangesh nigade for inquiries that concern Healix Infusion Therapy Inc by calling the company number (281) 295-4000, as your correspondence is most welcome. Additionally, the physical location of the single location of Healix Infusion Therapy Inc can be found at the coordinates 29.60897,-95.63047 as well as the street address 14140 Southwest Freeway # 400 in Sugar Land, Texas 77478.
For its online presence, you may visit Healix Infusion Therapy Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.